Lifecore Biomedical, Inc. De (LFCR) Restructuring Costs (2020 - 2025)

Lifecore Biomedical has reported Restructuring Costs for 6 years, with the latest figure at -$2.6 million in Q2 2025.

• On a quarterly basis, Restructuring Costs fell 456.91% year-over-year to -$2.6 million in Q2 2025; TTM through May 2025 was -$1.2 million, a 174.88% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 205.5% from the prior year.
• Restructuring Costs was -$2.6 million for Q2 2025 at Lifecore Biomedical, down from -$115000.0 in the prior quarter.
• The five-year high for Restructuring Costs was $10.5 million in Q2 2021, with the low at -$2.6 million in Q2 2025.
• Average Restructuring Costs over 5 years is $1.5 million, with a median of $754500.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs soared 9125.0% in 2024, then sank 456.91% in 2025.
• Over 5 years, Restructuring Costs stood at $627000.0 in 2021, then decreased by 10.21% to $563000.0 in 2022, then slumped by 72.11% to $157000.0 in 2023, then soared by 370.06% to $738000.0 in 2024, then tumbled by 456.91% to -$2.6 million in 2025.
• The last three Restructuring Costs figures came in at -$2.6 million (Q2 2025), -$115000.0 (Q1 2025), and $738000.0 (Q2 2024), per Business Quant data.